--- title: The Patient Advocate – A Critical Partner in Drug Development description: Patient caregivers are critical to patients & need to be prioritized & listened to in research to optimize drug development for rare diseases. image: https://blog.ubc.com/hubfs/Patient%20Advocate%20Featured%20Image.png --- [![UBC](https://blog.ubc.com/hs-fs/hubfs/raw_assets/public/UBC_December2021/images/logo-white.png?width=175&name=logo-white.png "UBC")](https://ubc.com/) - [Home](https://ubc.com/) - Services - [Full-Service Clinical Development](https://ubc.com/global-services/) - [Clinical Trial Management & Late Stage Research](https://ubc.com/global-services/trials-and-research/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/global-services/decentralized/) - [Patient & Physician Services](https://ubc.com/global-services/pps/) - [Pharmacovigilance](https://ubc.com/global-services/pharmacovigilance/) - [Risk Management Plans](https://ubc.com/global-services/risk-management/) - [Risk Evaluation and Mitigation Strategies (REMS)](https://ubc.com/global-services/rems/) - [Registries & Observational Studies](https://ubc.com/global-services/registries/) - [Safety & Epidemiology Consulting](https://ubc.com/global-services/epidemiology/) - [Become a Clinical Trial Investigator](https://ubc.com/global-services/become-an-investigator/) - [Patient Support Services](https://ubc.com/patient-support/) - [Access Services](https://ubc.com/patient-support/access-services/) - [Clinical Education](https://ubc.com/patient-support/clinical-education/) - [Connected Health](https://ubc.com/patient-support/connected-health/) - [In-Home Care Coordination](https://ubc.com/patient-support/care-coordination/) - [In-Workflow Services](https://ubc.com/patient-support/in-workflow-services/) - [Outcomes and Value](https://ubc.com/patient-support/outcomes-and-value/) - [Patient Engagement](https://ubc.com/patient-support/patient-engagement/) - [Real World Evidence](https://ubc.com/real-world-evidence/) - [RWE Consulting Practice](https://ubc.com/real-world-evidence/rwe-consulting/) - [Real World Data](https://ubc.com/real-world-evidence/real-world-data/) - [Mosaic Technology Platform](https://ubc.com/real-world-evidence/mosaic-technology-platform/) - [Automated Analytics Software](https://ubc.com/real-world-evidence/analytics-software/) - [Product Lifecycle Solutions](https://ubc.com/product-lifecycle/) - [Cell & Gene Therapy](https://ubc.com/product-lifecycle/cell-gene/) - [COVID-19](https://ubc.com/product-lifecycle/patient-care/) - [Oncology](https://ubc.com/product-lifecycle/oncology/) - [Nursing](https://ubc.com/product-lifecycle/nursing/) - [Rare Disease](https://ubc.com/product-lifecycle/rare-disease/) - [Technology](https://ubc.com/technology/) - [Automated Analytics Software](https://ubc.com/technology/automated-analytics-software/) - [Connected Health](https://ubc.com/technology/connected-health/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/technology/decentralized-studies-virtual-engagement/) - [Mosaic Technology Platform](https://ubc.com/technology/mosaic-technology-platform/) - [Patient Engagement](https://ubc.com/technology/engage/) - [Think Tank](https://blog.ubc.com/blog) - About - [About UBC](https://ubc.com/about/) - [Awards](https://ubc.com/about/awards/) - [Leadership Team](https://ubc.com/about/leadership/) - [Press Releases](https://ubc.com/about/press/) - [Careers](https://ubc.com/careers/) [SUBMIT RFI/RFP](https://ubc.com/contact/) Menu [![UBC](https://blog.ubc.com/hs-fs/hubfs/raw_assets/public/UBC_December2021/images/logo-white.png?width=175&name=logo-white.png "UBC")](https://ubc.com/) - [Home](https://ubc.com/) - Services - [Full-Service Clinical Development](https://ubc.com/global-services/) - [Clinical Trial Management & Late Stage Research](https://ubc.com/global-services/trials-and-research/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/global-services/decentralized/) - [Patient & Physician Services](https://ubc.com/global-services/pps/) - [Pharmacovigilance](https://ubc.com/global-services/pharmacovigilance/) - [Risk Management Plans](https://ubc.com/global-services/risk-management/) - [Risk Evaluation and Mitigation Strategies (REMS)](https://ubc.com/global-services/rems/) - [Registries & Observational Studies](https://ubc.com/global-services/registries/) - [Safety & Epidemiology Consulting](https://ubc.com/global-services/epidemiology/) - [Become a Clinical Trial Investigator](https://ubc.com/global-services/become-an-investigator/) - [Patient Support Services](https://ubc.com/patient-support/) - [Access Services](https://ubc.com/patient-support/access-services/) - [Clinical Education](https://ubc.com/patient-support/clinical-education/) - [Connected Health](https://ubc.com/patient-support/connected-health/) - [In-Home Care Coordination](https://ubc.com/patient-support/care-coordination/) - [In-Workflow Services](https://ubc.com/patient-support/in-workflow-services/) - [Outcomes and Value](https://ubc.com/patient-support/outcomes-and-value/) - [Patient Engagement](https://ubc.com/patient-support/patient-engagement/) - [Real World Evidence](https://ubc.com/real-world-evidence/) - [RWE Consulting Practice](https://ubc.com/real-world-evidence/rwe-consulting/) - [Real World Data](https://ubc.com/real-world-evidence/real-world-data/) - [Mosaic Technology Platform](https://ubc.com/real-world-evidence/mosaic-technology-platform/) - [Automated Analytics Software](https://ubc.com/real-world-evidence/analytics-software/) - [Product Lifecycle Solutions](https://ubc.com/product-lifecycle/) - [Cell & Gene Therapy](https://ubc.com/product-lifecycle/cell-gene/) - [COVID-19](https://ubc.com/product-lifecycle/patient-care/) - [Oncology](https://ubc.com/product-lifecycle/oncology/) - [Nursing](https://ubc.com/product-lifecycle/nursing/) - [Rare Disease](https://ubc.com/product-lifecycle/rare-disease/) - [Technology](https://ubc.com/technology/) - [Automated Analytics Software](https://ubc.com/technology/automated-analytics-software/) - [Connected Health](https://ubc.com/technology/connected-health/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/technology/decentralized-studies-virtual-engagement/) - [Mosaic Technology Platform](https://ubc.com/technology/mosaic-technology-platform/) - [Patient Engagement](https://ubc.com/technology/engage/) - [Think Tank](https://blog.ubc.com/blog) - About - [About UBC](https://ubc.com/about/) - [Awards](https://ubc.com/about/awards/) - [Leadership Team](https://ubc.com/about/leadership/) - [Press Releases](https://ubc.com/about/press/) - [Careers](https://ubc.com/careers/) - [Submit RFI/RFP](https://ubc.com/contact/) Anesthesiology 1. [Home](https://ubc.com/) 2. [Blog](https://blog.ubc.com/blog) 3. The Patient Advocate – A Critical Partner in Drug Development # The Patient Advocate – A Critical Partner in Drug Development *Wednesday, October 2, 2019* ![Shazia-Ahmad](https://blog.ubc.com/hs-fs/hubfs/Imported_Blog_Media/Shazia-Ahmad.jpeg?width=200&name=Shazia-Ahmad.jpeg)Patients are the heart of clinical research. It is important to understand factors affecting the patient outside of the clinical trial setting to better understand the disease, patient, and caregiver. Patient advocates bring non-scientific viewpoints, incorporating their own knowledge and experience and that of family members and other patients, into research to help make medical advances more timely and efficient for people affected by rare diseases. Patient advocates provide insight into how information can be utilized to enhance drug development. It truly is the advocate who brings the patient “voice” to research through their own rare disease journey.   I look forward to the [NORD Rare Summit](https://rarediseases.org/) each year as it gives me the opportunity to connect with patient advocates and truly understand the patient “voice” represented. It is a time to reflect on the work all of us do in the rare disease community whatever area we work in – be it drug development, clinical research, regulatory compliance, or patient advocacy. It is a wonderful opportunity to collaborate as a community, learn from one another, and most importantly return to our work with a renewed focus and passion for advancing treatments for rare disease patients. This year’s Summit will be held in Washington D.C., on October 21-22, bringing together stakeholders from across the rare disease space, including representatives from the FDA, NIH, orphan drug development industry, and most importantly, members of patient advocacy groups. Following the NORD Summit, I will be attending the [Neuromuscular Drug Development Summit (NMD)](https://nmd-summit.com/) in Boston, Oct. 25. I will be leading a panel on the topic of “Patient Advocacy Partnerships to Improve Real World Evidence (RWE) in Neuromuscular Drug Development.” Understanding the factors affecting the patient outside of the clinical trial setting to better understand the disease, patient and caregiver, can be done by integrated RWE and through patient advocates. The panel will include patient advocates sharing perspectives on what information can be learned and how it has been successfully incorporated into drug development. For any stakeholder in rare disease research or patient care, it really is imperative to not only understand the patient, and their journey to diagnosis and treatment, but also to take time to listen to the caregiver’s perspective. Unfortunately, for many patients, it takes years to find a diagnosis. For many, there is no diagnosis. We have heard the saying in medicine, “When you hear hoofbeats, think HORSE, not zebra.” To a clinician, this means to look for the obvious diagnosis, not the rare one. But sometimes what we encounter *is* a zebra. In this community, the zebras – or the rare – are common, but their experiences are very unique. Every patient and patient advocate has an incredible story, and I am proud to be an advocate for the rare disease community within the drug development space. To learn more about UBC, [click here](https://www.ubc.com/product-lifecycle/rare-disease) and [contact us](https://ubc.com/contact/) to find out how UBC can help you do more for your patients with rare diseases. ## Related Articles ## [Successful Strategies in Patient Recruitment and Retention](https://blog.ubc.com/blog/leveraging-successful-strategies-in-patient-recruitment-and-retention) Ophthalmic Drug Development Summit: Pre-Conference Workshop [Read More](https://blog.ubc.com/blog/leveraging-successful-strategies-in-patient-recruitment-and-retention) ## [Rare Disease Patients, Clinical Development, & Social Media](https://blog.ubc.com/blog/social-media-strategies-to-make-your-message-heard) The growth of social media interactions has played a critical role in advancing knowledge and awareness of... [Read More](https://blog.ubc.com/blog/social-media-strategies-to-make-your-message-heard) ## [UBC Partners with Surescripts for In-Workflow Specialty Patient Enrollment](https://blog.ubc.com/blog/ubc-partners-surescripts-specialty-patient-enrollment) Surescripts Specialty Patient Enrollment service will enable UBC to offer in-workflow enrollment to... [Read More](https://blog.ubc.com/blog/ubc-partners-surescripts-specialty-patient-enrollment) ![Footer Logo](https://blog.ubc.com/hs-fs/hubfs/raw_assets/public/UBC_December2021/images/logo-blue.jpg?width=113&name=logo-blue.jpg "Footer Logo") #### Quick Links - Subscribe to Think Tank - [Contact UBC](https://ubc.com/contact) - [Privacy](https://ubc.com/privacy-policy) - [Terms of Use](https://ubc.com/terms-of-use) - [Sitemap](https://ubc.com/sitemap) #### RECENT ARTICLES - [Planning for Diversity in Clinical Trials](https://blog.ubc.com/blog/planning-for-diversity-in-clinical-trials) - [Practical Considerations for Evidence Generation](https://blog.ubc.com/blog/practical-considerations-rwe) - [Supporting Patients and Families Through Case Management](https://blog.ubc.com/blog/supporting-patients-and-families-through-case-management) Copyright © 2017-2026 United BioSource LLC, all rights reserved. UBC®, CLÆRITY®, SæfetyWorks®, ExpressConnect® and UBC Pathways® are trademarks of United BioSource LLC. ![close button](https://blog.ubc.com/hubfs/close.png) ### Subscribe to Think Tank #### Look for more industry-related insight coming soon! Thank you for your interest in UBC’s thought leadership!